BioScience Health Innovations (BHIC) Receivables - Other (2024 - 2025)

BioScience Health Innovations (BHIC) reported Receivables - Other of $137718.0 for Q4 2025, up 531.79% year-over-year from $21798.0 in Q4 2024, and up 531.79% quarter-over-quarter from $21798.0 in Q4 2024.

BioScience Health Innovations (BHIC) Receivables - Other (2024 - 2025) Analysis & Trends

BioScience Health Innovations (BHIC) has 2 years of Receivables - Other data on file, last reported at $137718.0 in Q4 2025.

  • Receivables - Other for Q4 2025 came in at $137718.0, up 531.79% year-over-year; the trailing twelve-month figure through Dec 2025 was $137718.0 (up 531.79% YoY), and the FY2025 annual result was $137718.0, up 531.79% from the prior year.
  • Receivables - Other rose to $137718.0 in Q4 2025 per BHIC's latest filing, from $21798.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $137718.0 in Q4 2025 and troughed at $21798.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 High Tide 558.20 Mn 531.28 Mn 32.00 Mn
2 Wellgistics Health 385.01 Mn 384.95 Mn 170,221.00
3 Petmed Express 35.71 Mn 8.80 Mn 9.46 Mn
4 Scienture Holdings 14.72 Mn 14.72 Mn 53,850.00
5 Ridgetech 15.50 -4.11 Mn -
6 Scientist Home Future Health - - 32,589.00
7 BioScience Health Innovations - - 485,596.00
8 Rest Ez - - -
9 Polomar Health Services - - 550,489.00

Historic Data

Download Data
DateValue
Dec 31, 2025 137,718.00
Dec 31, 2025 137,718.00
Dec 31, 2024 21,798.00
Dec 31, 2024 21,798.00